A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Schizophrenia
Interventions
DRUG

olanzapine

10-15 mg (using 5-mg or 10-mg tablets) once daily flexible dosing for 6 months

DRUG

paliperidone ER

6-mg or 9-mg tablet once daily flexible dosing for 6 months

Trial Locations (46)

Unknown

Buenos Aires

Córdoba

Mendoza

Alexandria

Cairo

El Banfaig 2 District

Pärnu

Tallinn

Tartu

Allonnes

Bron

Dijon

Limoges

Montberon

Athens

Amman

Jelgava

Liepāja

Riga

Sigulda

Strenči

Beirut

Kaunas

Vilnius

Cluj-Napoca

Craiova

Oradea

Sibiu

Tg Mures

Bratislava

Michalovce

Rimavská Sobota

Cape Town

Johannesburg

A Coruña

Alicante

Barcelona

Elche

Madrid

Santander

Vic

Zamora

Ankara

Bursa

Istanbul

Manisa

Sponsors
All Listed Sponsors
lead

Janssen-Cilag International NV

INDUSTRY

NCT00645099 - A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter